TrialThe European respiratory journal2012

Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study.

Edward Kerwin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.